4.7 Editorial Material

Association of IL2RA and IL2RB with rheumatoid arthritis: a replication study in a Dutch population

期刊

ANNALS OF THE RHEUMATIC DISEASES
卷 68, 期 11, 页码 1789-1790

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/ard.2008.106393

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Rheumatology

Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis

Lotte van Ouwerkerk, Maarten Boers, Paul Emery, Pascal H. P. de Jong, Robert B. M. Landewe, Willem Lems, Josef S. Smolen, Patrick Verschueren, Tom W. J. Huizinga, Cornelia F. Allaart, Sytske Anne Bergstra

Summary: This study investigated whether patients with rheumatoid arthritis (RA) can discontinue glucocorticoids (GC) after GC 'bridging' in the initial treatment step and identified factors that may affect this. The probability of using GC decreased over time after bridging therapy ended, while the probability of continuous GC use increased. In oral GC bridging studies, the probabilities of later and continuous GC use and the cumulative GC doses were higher compared to studies that included parenteral GC bridging.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Rheumatology

Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022

Kevin L. Winthrop, John D. Isaacs, Philip J. Mease, Dimitrios T. Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R. Lories, Daniel Aletaha, Iain B. McInnes, Tom W. J. Huizinga, Reinhard E. Voll, Ellen M. Gravallese, Ferry C. Breedveld, Josef S. Smolen

Summary: This article summarizes the unmet clinical and scientific needs in the field of rheumatology. It highlights the importance of clinical trial design innovation and the need to better understand the natural history of rheumatic diseases. The article also identifies the specific unmet needs in different rheumatological disease-specific groups and emphasizes the importance of developing therapies and therapeutic strategies for treatment-refractory disease.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Review Immunology

Inducibility or predestination? Queries and concepts around drug-free remission in rheumatoid arthritis

Bernardo D'Onofrio, Annette van der Helm-van Mil, Tom W. J. Huizinga, Elise van Mulligen

Summary: Drug-free remission is the desired outcome for RA patients, linked to symptom resolution and restoration of normal functioning. Early initiation of DMARD, strict monitoring, and drug adjustments are crucial for achieving DFR, and ACPA-negative patients are more likely to maintain remission.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2023)

Article Immunology

IgG Fab Glycans Hinder FcRn-Mediated Placental Transport

Mikhail Volkov, Maximilian Brinkhaus, Karin A. van Schie, Albert Bondt, Theresa Kissel, Elvera J. van der Kooi, Arthur E. H. Bentlage, Carolien A. M. Koeleman, Steven W. de Taeye, Ninotska I. Derksen, Radboud J. E. M. Dolhain, Ute Braig-Scherer, Tom W. J. Huizinga, Manfred Wuhrer, Rene E. M. Toes, Gestur Vidarsson, Diane van der Woude

Summary: Glycosylation in the Fc and Fab regions of antibodies can affect their function and binding. Fab glycans negatively impact the interaction between IgG and hFcRn and reduce the transport of IgG across the placenta. Fab-glycosylated antibodies are frequently associated with autoimmune and malignant disorders and may have potential harmful effects.

JOURNAL OF IMMUNOLOGY (2023)

Review Rheumatology

Glycobiology of rheumatic diseases

Theresa Kissel, Rene E. M. Toes, Thomas W. J. Huizinga, Manfred Wuhrer

Summary: Glycosylation is a common modification that affects protein stability and interactions. It plays a significant role in rheumatic diseases, influencing inflammatory processes and disease progression. Understanding the impact of glycosylation on plasma proteins, cells, and tissues opens up potential interventions for the treatment of these diseases.

NATURE REVIEWS RHEUMATOLOGY (2023)

Article Rheumatology

Autoreactive B cell responses targeting nuclear antigens in systemic sclerosis: Implications for disease pathogenesis

Sophie I. E. Liem, Sam Neppelenbroek, Cynthia M. Fehres, Corrie Wortel, Rene E. M. Toes, Tom W. J. Huizinga, Hans U. Scherer, Jeska K. de Vries-Bouwstra

Summary: A hallmark of disease pathogenesis of systemic sclerosis (SSc) is the presence of autoreactive B cell responses targeting nuclear proteins. Autoantibodies serve as diagnostic biomarkers in SSc and can help identify clinical phenotypes of the disease. Understanding the contribution of antinuclear autoantibodies and their underlying B cell response is crucial in the management and treatment of SSc.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2023)

Article Rheumatology

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies

Sophie I. E. Liem, Sam Neppelenbroek, Cynthia M. Fehres, Brigitte A. Wevers, Rene E. M. Toes, Cornelia F. Allaart, Tom W. J. Huizinga, Hans Ulrich Scherer, Jeska K. De Vries-Bouwstra

Summary: Early diagnosis of systemic sclerosis (SSc) is important. The most frequent SSc-specific autoantibodies are anti-centromere antibodies (ACA) and anti-topoisomerase I antibodies (ATA). ATA is associated with severe disease course. More detailed characterisation of the ATA-response in SSc might improve prognostication.

RMD OPEN (2023)

Article Rheumatology

Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment

Sascha L. Heckert, Sytske Anne Bergstra, Yvonne P. M. Goekoop-Ruiterman, Melek Gueler-Yueksel, Willem F. Lems, Xanthe M. E. Matthijssen, Maikel van Oosterhout, Tom W. J. Huizinga, Cornelia F. Allaart

Summary: This study aimed to investigate whether the frequency of local joint inflammation in rheumatoid arthritis (RA) is associated with radiographic joint damage progression in that joint. Data from 473 RA patients were analyzed, and it was found that long-term cumulative local joint swelling is associated with radiographic joint damage progression in the same joint.

RMD OPEN (2023)

Article Rheumatology

Clinical outcome in patients with suspected inflammatory neuropsychiatric lupus treated with immunosuppression: an observational cohort study

Rory C. Monahan, Liesbeth J. J. van de Voorde, Rolf Fronczek, Jeroen de Bresser, Jeroen Eikenboom, Margreet Kloppenburg, Huub A. M. Middelkoop, Gisela M. Terwindt, Nic J. A. van der Wee, Tom W. J. Huizinga, Gerda M. Steup-Beekman

Summary: This study investigated the short-term and long-term outcomes of inflammatory NPSLE with immunosuppressive treatment. The results showed that approximately 70% of cases had improvement in neuropsychiatric symptoms after treatment.

LUPUS SCIENCE & MEDICINE (2023)

Article Rheumatology

Mouth opening in systemic sclerosis: its course over time, determinants and impact on mouth handicap

Sarah J. H. Khidir, Maaike Boonstra, Sytske Anne Bergstra, Gerry W. M. Boerrigter, Elles M. Voog-van der Harst, Maarten K. Ninaber, Nina Ajmone Marsan, Tom W. J. Huizinga, Annette H. M. van der Helm-van Mil, Jeska K. de Vries-Bouwstra

Summary: This study aimed to investigate the course of maximal mouth opening in systemic sclerosis patients and determine the factors associated with smaller maximal mouth opening over time. The results showed that a majority of patients had stable maximal mouth opening, but those with more severe organ involvement had a smaller maximal mouth opening over time. Smaller maximal mouth opening was also associated with more mouth handicap.

JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2023)

Letter Rheumatology

Comment on: Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database

Jacopo Ciaffi, Sophie I. E. Liem, Nina M. van Leeuwen, Cornelia F. Allaart, Tom W. J. Huizinga, Jeska K. de Vries-Bouwstra

RHEUMATOLOGY (2023)

Article Rheumatology

Patterns of clinical joint inflammation in juvenile idiopathic arthritis

Sascha L. Heckert, Petra C. E. Hissink-Muller, J. Merlijn van den Berg, Dieneke Schonenberg-Meinema, Lisette W. A. van Suijlekom-Smit, Marion A. J. van Rossum, Yvonne Koopman, Rebecca ten Cate, Danielle M. C. Brinkman, Tom W. J. Huizinga, Cornelia F. Allaart, Sytske Anne Bergstra

Summary: We studied the patterns of joint inflammation in JIA and found that joints with inflammation at disease onset tend to have recurrent episodes of inflammation during follow-up. This suggests that local factors may contribute to the occurrence of JIA flares.

RMD OPEN (2023)

Letter Rheumatology

IgM antibodies against acetylated proteins as a possible starting point of the anti-modified protein antibody response in rheumatoid arthritis

Tineke J. van Wesemael, Sanne Reijm, Atsushi Kawakami, Annemarie L. Dorjee, Gerrie Stoeken, Takahiro Maeda, Shin-ya Kawashiri, Tom W. J. Huizinga, Mami Tamai, Rene E. M. Toes, Diane van der Woude

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Rheumatology

Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?

Lotte van Ouwerkerk, Patrick Verschueren, Maarten Boers, Paul Emery, Pascal Hendrik Pieter de Jong, Robert B. M. Landewe, Willem Lems, Josef S. Smolen, Tom W. J. Huizinga, Cornelia F. Allaart, Sytske Anne Bergstra

Summary: In patients with rheumatoid arthritis (RA), the use of glucocorticoids (GC) as bridging therapy resulted in a more rapid clinical improvement and fewer changes in medication, but similar long-term GC use compared with patients who did not receive bridging therapy.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Rheumatology

Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations

Emma C. de Moel, Leendert A. Trouw, Chikashi Terao, Nimmisha Govind, Mohammed Tikly, Hani El-Gabalawy, Irene Smolik, Holger Bang, Tom W. J. Huizinga, Rene E. M. Toes, Diane van der Woude

Summary: Rheumatoid arthritis (RA) occurs in different ethnic populations worldwide. This study revealed that anti-modified protein antibodies (AMPA) can be detected in RA patients across different continents and ethnicities, suggesting a common pathway involved in AMPA development. However, differences in AMPA levels and associated factors were observed among the different populations.

ARTHRITIS RESEARCH & THERAPY (2023)

暂无数据